DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksClose Window
References
Lansky AJ, Schofer J, Tchetche D. et al.
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.
Eur Heart J 2015;
36 (31) 2070-2078
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.